Martial Lantche Wandji

Statistics

Publications

Citations

180

H-Index

Active since

2020

Affiliations

Centre Hospitalier Universitaire de Montpellier(Current)

Université de Dschang

Central Hospital of Yaoundé

Inserm

Université de Montpellier

Martial Lantche Wandji is an author at Centre Hospitalier Universitaire de Montpellier specializing in antiretroviral therapy, pharmacotherapy, and antiviral therapy.

Publications per year

2020–2020

Publications

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

Alexandra Calmy, Tamara Tovar-Sanchez, Charles Kouanfack et al. · The Lancet HIV · 2020 · 164 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial)

Marwân‐al‐Qays Bousmah, Marie Libérée Nishimwe, Tamara Tovar-Sanchez et al. · PharmacoEconomics · 2020 · 16 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

1–2 of 2